Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

From the New England Journal of Medicine— Extended-release naltrexone, a sustained-release monthly injectable formulation of the full mu-opioid receptor antagonist, is effective for the prevention of relapse to opioid dependence. Data supporting its effectiveness in U.S. criminal justice populations are limited.

Read study.